Study details first therapeutic melanoma vaccine

submitted by: mdanderson
Scientists, led by Patrick Hwu, M.D., of MD Anderson Cancer Center, and Douglas Schwartzentruber, M.D., of Goshen Center for Cancer Care, have developed a vaccine for advanced melanoma. When combined with Interleuken-2, the cocktail stimulates the body's immune system to recognize and ultimately fight cancer cells. Drs. Hwu and Schwartzentruber explain their findings, which are published in the New England Journal of Medicine, and discuss other recent advances in the treatment and research...

Von Hippel Lindau - Rare Genetic Disease

submitted by: mdanderson

Von Hippel Lindau disease (VHL) is an inherited gene mutation that causes tumors to form in areas containing large numbers of blood vessels like in the eyes, brain, spinal cord, kidney, pancreas and inner ear. Eric Jonasch, associate professor in MD Anderson Cancer Center's Genitourinary Medical Oncology Department, is one of the few doctors in the world that treats this rare disease and he discusses VHL in this episode.

Treatment Could Provide Relief for Leukemia Patients

submitted by: mdanderson
At least 40% of leukemia patients seen at MD Anderson Cancer Center in Houston, experience pneumonia in their initial treatments. Scott Evans, M.D., assistant professor in Pulmonary Medicine, Evans and his colleagues have identified a combination of two small molecules that stimulate the lungs to become resistant to infection. They're goal is to use this combination to prevent pneumonia in patients with acute leukemia. Evans describes the research that's being done. http://bit.ly/iMGN4b

Lymphedema: Basics, Management and New Research

submitted by: mdanderson
http://bit.ly/CancerNL Many women and men develop lymphedema following cancer surgery. Its onset can occur as far out as two--five years later. Kathleen Smalky, M.D., associate professor in the Department of General Internal Medicine at MD Anderson Cancer Center, explains how lymphedema occurs, why self-care is important, and discusses what research is being conducted to help those who have this common condition.

Genetic Testing for Cancer: Is It Worth It?

submitted by: mdanderson
Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening How often you should get tested for breast cancer depends on your chances for getting the disease. If you are at increased risk for breast cancer, you may need to start screening exams at an earlier age, get additional tests or be tested more often. Learn when genetic testing makes sense for you. Dr. Banu Arun, Professor of Breast Medical Oncology and Co-Director of Clinical Cancer Genetics...

Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance

submitted by: mdanderson

In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr. Robert Gagel who with his team helped to bring about the FDA's approval of vandetanib talks about the drug, the research and it's benefit to medullary thyroid cancer patients.

Larry Kwak, M.D., Ph.D., named to the 2010 TIME 100 Most Influential People list

submitted by: mdanderson
http://bit.ly/mGp6xh Larry Kwak, M.D., Ph. D., chair of the department of Lymphoma and Myeloma at MD Anderson, who has devoted 20 years to investigating the science of cancer vaccines, specifically a personalized therapy for follicular lymphoma, was named in 2010 as one of Time magazine's 100 most influential people. Kwak and a team led by scientists at MD Anderson reported in the online version of Journal of Clinical Oncology that a lymphoma vaccine uniquely tailored for each patient...